Supermicro Q2 2023 Earnings Report
Key Takeaways
Supermicro reported a record quarter in fiscal Q2 2023, with revenue just over $1.8 billion, a 54% increase year-over-year. The company's eighth consecutive quarter of outstanding growth effectively doubled their annual revenue. Net income was $176 million, and non-GAAP diluted net income per common share was $3.26.
Net sales reached $1.80 billion, compared to $1.17 billion in the same quarter last year.
Gross margin was 18.7%, up from 14.0% in the same quarter last year.
Net income was $176 million, significantly higher than the $42 million in the same quarter last year.
Non-GAAP diluted net income per common share was $3.26, compared to $0.88 in the same quarter last year.
Supermicro
Supermicro
Forward Guidance
For the third quarter of fiscal year 2023, the Company expects net sales of $1.42 billion to $1.52 billion, GAAP net income per diluted share of $1.75 to $2.02 and non-GAAP net income per diluted share of $1.88 to $2.14. For fiscal year 2023, the Company maintains its guidance for net sales from a range of $6.5 billion to $7.5 billion, GAAP net income per diluted share from a range of $8.50 to $11.00, and non-GAAP net income per diluted share from a range of $9.00 to $11.30.
Positive Outlook
- Net sales are expected to be between $1.42 billion and $1.52 billion.
- GAAP net income per diluted share is projected to be between $1.75 and $2.02.
- Non-GAAP net income per diluted share is expected to range from $1.88 to $2.14.
- Maintains net sales guidance from a range of $6.5 billion to $7.5 billion for fiscal year 2023.
- Maintains GAAP net income per diluted share from a range of $8.50 to $11.00 for fiscal year 2023.
Challenges Ahead
- The projections assume a tax rate of approximately 15.9% for GAAP and 16.9% for non-GAAP.
- The outlook for Q3 includes approximately $9 million in expected stock-based compensation and other expenses.
- The projections assume a fully diluted share count of 57 million shares for GAAP and 58 million shares for non-GAAP.
- The projections assume a tax rate of approximately 19.2% for annual GAAP and 19.8% for non-GAAP.
- The outlook for fiscal year 2023 includes approximately $33 million in expected stock-based compensation and other expenses.